{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:32:46Z","timestamp":1761060766470},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10620-019-05593-8","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T12:02:57Z","timestamp":1552910577000},"page":"968-975","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Multidisciplinary Approach to HCC Management: How Can This Be Done?"],"prefix":"10.1007","volume":"64","author":[{"given":"Melissa M.","family":"Gadsden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"5593_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374\u20131403.","journal-title":"Eur J Cancer"},{"key":"5593_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"5593_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cgh.2011.11.008","volume":"10","author":"J Guy","year":"2012","unstructured":"Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N. Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2012;10:354\u2013362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5593_CR4","doi-asserted-by":"publisher","first-page":"c951","DOI":"10.1136\/bmj.c951","volume":"340","author":"C Taylor","year":"2010","unstructured":"Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.","journal-title":"BMJ"},{"key":"5593_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","volume":"42","author":"B Pillay","year":"2016","unstructured":"Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56\u201372.","journal-title":"Cancer Treat Rev"},{"key":"5593_CR6","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.14694\/EdBook_AM.2014.34.e461","volume":"34","author":"NS El Saghir","year":"2014","unstructured":"El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014;34:e461\u2013e466.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"5593_CR7","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/cncr.22266","volume":"107","author":"EA Newman","year":"2006","unstructured":"Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;107:2346\u20132351.","journal-title":"Cancer"},{"key":"5593_CR8","doi-asserted-by":"publisher","first-page":"e2718","DOI":"10.1136\/bmj.e2718","volume":"344","author":"EM Kesson","year":"2012","unstructured":"Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012;344:e2718.","journal-title":"BMJ"},{"key":"5593_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K","volume":"91","author":"JH Chang","year":"2001","unstructured":"Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer. 2001;91:1231\u20131237.","journal-title":"Cancer"},{"key":"5593_CR10","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1245\/s10434-018-6599-y","volume":"25","author":"D Garcia","year":"2018","unstructured":"Garcia D, Spruill LS, Irshad A, Wood J, Kepecs D, Klauber-DeMore N. The value of a second opinion for breast cancer patients referred to a National Cancer Institute (NCI)-designated cancer center with a multidisciplinary breast tumor board. Ann Surg Oncol. 2018;25:2953\u20132957.","journal-title":"Ann Surg Oncol"},{"key":"5593_CR11","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.5489\/cuaj.5150","volume":"12","author":"K Scarberry","year":"2018","unstructured":"Scarberry K, Ponsky L, Cherullo E, et al. Evaluating the impact of the genitourinary multidisciplinary tumour board: should every cancer patient be discussed as standard of care? Can Urol Assoc J. 2018;12:e403\u2013e408.","journal-title":"Can Urol Assoc J"},{"key":"5593_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.otohns.2010.07.020","volume":"143","author":"SA Wheless","year":"2010","unstructured":"Wheless SA, McKinney KA, Zanation AM. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryngol Head Neck Surg. 2010;143:650\u2013654.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5593_CR13","first-page":"1321","volume":"20","author":"HO Greer","year":"2010","unstructured":"Greer HO, Frederick PJ, Falls NM, et al. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. Int J Gynecol Cancer. 2010;20:1321\u20131325.","journal-title":"Int J Gynecol Cancer"},{"key":"5593_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.urolonc.2009.04.008","volume":"29","author":"R Kurpad","year":"2011","unstructured":"Kurpad R, Kim W, Rathmell WK, et al. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? Urol Oncol. 2011;29:378\u2013382.","journal-title":"Urol Oncol"},{"key":"5593_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10147-011-0362-8","volume":"18","author":"P Hagen van","year":"2013","unstructured":"van Hagen P, Spaander MC, van der Gaast A, et al. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study. Int J Clin Oncol\/Jpn Soc Clin Oncol. 2013;18:214\u2013219.","journal-title":"Int J Clin Oncol\/Jpn Soc Clin Oncol"},{"key":"5593_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/DCR.0000000000000390","volume":"58","author":"RC Snelgrove","year":"2015","unstructured":"Snelgrove RC, Subendran J, Jhaveri K, et al. Effect of multidisciplinary cancer conference on treatment plan for patients with primary rectal cancer. Dis Colon Rectum. 2015;58:653\u2013658.","journal-title":"Dis Colon Rectum"},{"key":"5593_CR17","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1245\/s10434-014-4163-y","volume":"22","author":"J Oxenberg","year":"2015","unstructured":"Oxenberg J, Papenfuss W, Esemuede I, et al. Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients. Ann Surg Oncol. 2015;22:1533\u20131539.","journal-title":"Ann Surg Oncol"},{"key":"5593_CR18","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.athoracsur.2014.11.019","volume":"99","author":"HM Schmidt","year":"2015","unstructured":"Schmidt HM, Roberts JM, Bodnar AM, et al. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study. Ann Thorac Surg. 2015;99:1719\u20131724.","journal-title":"Ann Thorac Surg"},{"key":"5593_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/pbc.26201","volume":"64","author":"A Thenappan","year":"2017","unstructured":"Thenappan A, Halaweish I, Mody RJ, et al. Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer. 2017;64:254\u2013258.","journal-title":"Pediatr Blood Cancer"},{"key":"5593_CR20","doi-asserted-by":"publisher","first-page":"e8089","DOI":"10.1097\/MD.0000000000008089","volume":"96","author":"B Lee","year":"2017","unstructured":"Lee B, Kim K, Choi JY, et al. Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: a prospective study. Medicine (Baltimore). 2017;96:e8089.","journal-title":"Medicine (Baltimore)"},{"key":"5593_CR21","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28:2852\u20132859.","journal-title":"Ann Oncol"},{"key":"5593_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1200\/JGO.2015.000158","volume":"1","author":"NS Saghir El","year":"2015","unstructured":"El Saghir NS, Charara RN, Kreidieh FY, et al. Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology international survey. J Glob Oncol. 2015;1:57\u201364.","journal-title":"J Glob Oncol"},{"key":"5593_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1245\/s10434-013-3419-2","volume":"21","author":"KC Soares","year":"2014","unstructured":"Soares KC, Cosgrove DC, Herman JM, Pawlik TM. Multidisciplinary clinic in the management of hepatocellular carcinoma. Ann Surg Oncol. 2014;21:1059\u20131061.","journal-title":"Ann Surg Oncol"},{"key":"5593_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1046\/j.1523-5394.1999.76007.x","volume":"7","author":"J Cleave Van","year":"1999","unstructured":"Van Cleave J, Devine P, Odom-Ball P. Multidisciplinary care of hepatocellular carcinoma. Cancer Pract. 1999;7:302\u2013308.","journal-title":"Cancer Pract"},{"key":"5593_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/lt.20012","volume":"10","author":"P Sharma","year":"2004","unstructured":"Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl. 2004;10:36\u201341.","journal-title":"Liver Transpl"},{"key":"5593_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/JMDH.S41206","volume":"6","author":"GS Cohen","year":"2013","unstructured":"Cohen GS, Black M. Multidisciplinary management of hepatocellular carcinoma: a model for therapy. J Multidiscip Healthc. 2013;6:189\u2013195.","journal-title":"J Multidiscip Healthc"},{"key":"5593_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1600-6143.2005.00750.x","volume":"5","author":"FY Yao","year":"2005","unstructured":"Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl. 2005;5:795\u2013804.","journal-title":"Am J Transpl"},{"key":"5593_CR28","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/jamasurg.2014.1711","volume":"149","author":"K Lau","year":"2014","unstructured":"Lau K, Salami A, Barden G, et al. The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the Veterans Affairs system. JAMA Surg. 2014;149:1153\u20131161.","journal-title":"JAMA Surg"},{"key":"5593_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u2013390.","journal-title":"N Engl J Med"},{"key":"5593_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000333276","volume":"81","author":"HC Park","year":"2011","unstructured":"Park HC, Seong J, Tanaka M, et al. Multidisciplinary management of nonresectable hepatocellular carcinoma. Oncology. 2011;81:134\u2013140.","journal-title":"Oncology"},{"key":"5593_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1477-2574.2010.00184.x","volume":"12","author":"E Dixon","year":"2010","unstructured":"Dixon E, Abdalla E, Schwarz RE, Vauthey JN. AHPBA\/SSO\/SSAT sponsored consensus conference on multidisciplinary treatment of hepatocellular carcinoma. HPB (Oxford). 2010;12:287\u2013288.","journal-title":"HPB (Oxford)"},{"key":"5593_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358\u2013380.","journal-title":"Hepatology"},{"key":"5593_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723\u2013750.","journal-title":"Hepatology"},{"key":"5593_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/13651820802356572","volume":"10","author":"TT Chang","year":"2008","unstructured":"Chang TT, Sawhney R, Monto A, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008;10:405\u2013411.","journal-title":"HPB (Oxford)"},{"key":"5593_CR35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1245\/s10434-013-3413-8","volume":"21","author":"AC Yopp","year":"2014","unstructured":"Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21:1287\u20131295.","journal-title":"Ann Surg Oncol"},{"key":"5593_CR36","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","volume":"152","author":"M Serper","year":"2017","unstructured":"Serper M, Taddei TH, Mehta R, et al. Association of provider specialty and multi-disciplinary care with hepatocellular carcinoma treatment and mortality. Gastroenterology. 2017;152:1954\u20131964.","journal-title":"Gastroenterology"},{"key":"5593_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cgh.2017.07.024","volume":"16","author":"DE Kaplan","year":"2018","unstructured":"Kaplan DE, Chapko MK, Mehta R, et al. Healthcare costs related to treatment of hepatocellular carcinoma among veterans with cirrhosis in the United States. Clin Gastroenterol Hepatol. 2018;16:106\u2013114.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5593_CR38","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1200\/JOP.2014.000679","volume":"11","author":"AC Salami","year":"2015","unstructured":"Salami AC, Barden GM, Castillo DL, et al. Establishment of a regional virtual tumor board program to improve the process of care for patients with hepatocellular carcinoma. J Oncol Pract. 2015;11:e66\u2013e74.","journal-title":"J Oncol Pract"},{"key":"5593_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/lt.21941","volume":"16","author":"MJ Englesbe","year":"2010","unstructured":"Englesbe MJ, Kubus J, Muhammad W, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83\u201390.","journal-title":"Liver Transpl"},{"key":"5593_CR40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/hpb.12280","volume":"16","author":"L Gashin","year":"2014","unstructured":"Gashin L, Tapper E, Babalola A, et al. Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinoma. HPB (Oxford). 2014;16:1009\u20131015.","journal-title":"HPB (Oxford)"},{"key":"5593_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jso.24500","volume":"115","author":"B Charriere","year":"2017","unstructured":"Charriere B, Muscari F, Maulat C, et al. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J Surg Oncol. 2017;115:330\u2013336.","journal-title":"J Surg Oncol"},{"key":"5593_CR42","doi-asserted-by":"publisher","first-page":"ii15","DOI":"10.1093\/annonc\/mdt053","volume":"24","author":"C Barone","year":"2013","unstructured":"Barone C, Koeberle D, Metselaar H, Parisi G, Sansonno D, Spinzi G. Multidisciplinary approach for HCC patients: hepatology for the oncologists. Ann Oncol. 2013;24:ii15\u2013ii23.","journal-title":"Ann Oncol"},{"key":"5593_CR43","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cgh.2014.03.038","volume":"13","author":"WE Naugler","year":"2015","unstructured":"Naugler WE, Alsina AE, Frenette CT, Rossaro L, Sellers MT. Building the multidisciplinary team for management of patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2015;13:827\u2013835.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5593_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329\u2013338.","journal-title":"Semin Liver Dis"},{"key":"5593_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52\u201360.","journal-title":"Semin Liver Dis"},{"key":"5593_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1470-2045(11)70010-9","volume":"12","author":"V Mazzaferro","year":"2011","unstructured":"Mazzaferro V, Majno P. Principles for the best multidisciplinary meetings. Lancet Oncol. 2011;12:323\u2013325.","journal-title":"Lancet Oncol"},{"key":"5593_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.disamonth.2008.03.005","volume":"54","author":"WE Naugler","year":"2008","unstructured":"Naugler WE, Schwartz JM. Hepatocellular carcinoma. Dis Mon. 2008;54:432\u2013444.","journal-title":"Dis Mon"},{"key":"5593_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-3083.2009.02322.x","volume":"70","author":"A Soleimani","year":"2009","unstructured":"Soleimani A, Berntsen A, Svane IM, Pedersen AE. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate. Scand J Immunol. 2009;70:481\u2013489.","journal-title":"Scand J Immunol"},{"key":"5593_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1155\/2010\/410574","volume":"24","author":"KW Burak","year":"2010","unstructured":"Burak KW, Kneteman NM. An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm. Can J Gastroenterol. 2010;24:643\u2013650.","journal-title":"Can J Gastroenterol"},{"key":"5593_CR50","unstructured":"Aytaman Aea. VA Collaborative Consensus on a Pathway for the Development of a Multidisciplinary Team to Manage Hepatocellular Carcinoma. 2017; \n                    https:\/\/www.hepatitis.va.gov\/pdf\/HCC-multidisciplinary-management-best-practices.pdf\n                    \n                  ."},{"key":"5593_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/annonc\/mdx781","volume":"29","author":"SP Somashekhar","year":"2018","unstructured":"Somashekhar SP, Sepulveda MJ, Puglielli S, et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol. 2018;29:418\u2013423.","journal-title":"Ann Oncol"},{"key":"5593_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12920-016-0234-1","volume":"9","author":"ML McGowan","year":"2016","unstructured":"McGowan ML, Ponsaran RS, Silverman P, Harris LN, Marshall PA. A rising tide lifts all boats\u201d: establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease. BMC Med Geno. 2016;9:71.","journal-title":"BMC Med Geno"},{"key":"5593_CR53","doi-asserted-by":"publisher","first-page":"e000398","DOI":"10.1136\/esmoopen-2018-000398","volume":"3","author":"C Rolfo","year":"2018","unstructured":"Rolfo C, Manca P, Salgado R, et al. Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer. ESMO Open. 2018;3:e000398.","journal-title":"ESMO Open"},{"key":"5593_CR54","first-page":"469A","volume":"62","author":"E Egert","year":"2015","unstructured":"Egert E, Johnson R, Watts M, et al. A regional multidisciplinary liver tumor board improves access to hepatocellular carcinoma treatment for patients geographically distant from tertiary medical center. Abstract #521 Hepatology. 2015;62:469A.","journal-title":"Abstract #521 Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05593-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05593-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05593-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:17:05Z","timestamp":1584404225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05593-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["5593"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05593-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"18 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}